Bupropion in psoriasis and atopic dermatitis: Decreased tumor necrosis factor-α?

Psychosomatic Medicine

Volumn 65, Issue 4, 2003, Pages 719-

  Altschuler, Eric Lewin ^a   Kast, Richard E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CYCLIC AMP; MONOAMINE OXIDASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ATOPIC DERMATITIS; CROHN DISEASE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LETTER; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; RHEUMATOID ARTHRITIS;

BUPROPION; CROHN DISEASE; DERMATITIS, ATOPIC; HUMANS; MONOAMINE OXIDASE INHIBITORS; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041843815     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PSY.0000073874.55003.EE     Document Type: Letter

References (12)

1. Modell JG, Boyce S, Taylor E, Katholi C. Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study. Psychosom Med 2002;64:835-40.
2. Kast RE, Altschuler EL. Remission of Crohn's disease on bupropion?: two case studies [abstract]. Am J Gastroenterol 2000;95: 2496.
3. Kast RE, Altschuler EL. Remission of Crohn's disease on bupropion. Gastroenterology 2001;121:1260-1.
4. Altschuler EL. Monoamine oxidase inhibitors in rheumatoid arthritis - anti-tumor necrosis factor? Int J Immunopharmacol 2000;22: 1007-8.
5. Alpsoy E, Ozcan E, Cetin L, Ozgur O, Er H, Yilmaz E, Karaman T. Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy? J Am Acad Dermatol 1998;38: 197-200.
6. Kast RE. Crohn's disease remission with phenelzine treatment. Gastroenterology 1998; 115:1034-5.
7. Lieb J. Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors. Int J Immunopharmacol 1983;5:353-7.
8. Talmadge J, Scott R, Castelli P, Newman-Tarr T, Lee J. Molecular pharmacology of the beta-adrenergic receptor on THP-1 cells. Int J Immunopharmacol 1993;15:219-28.
9. Guirao X, Kumar A, Katz J, Smith M, Lin E, Keogh C, Calvano SE, Lowry SF. Catecholamines increase monocyte TNF receptors and inhibit TNF through β-2 adrenoreceptor activation. Am J Physiol 1997;273:E1203-8.
10. Scallon B, Cai A, Solowski N, Rosenberg A, Song X-Y, Shealy D, Wagner C. Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 2002;301:418-26.
11. Junghans V, Gutgesell C, Jung T, Neumann C. Epidermal cytokines IL-1beta, TNF-alpha, and IL-12 in patients with atopic dermatitis: response to application of house dust mite antigens. J Invest Dermatol 1998;111:1184-8.
12. de Vries IJ, Langeveld-Wildschut EG, van Reijsen FC, Dubois GR, van den Hoek JA, Bihari IC, van Wichen D, de Weger RA, Knol EF, Thepen T, Bruijnzeel-Koomen CA. Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol 1998;102:461-8.